| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*
Cooperative Research Center for Vaccine Technology, Queensland Institute of Medical Research, Royal Brisbane Hospital, Queensland, Australia; and
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
Immunity induced by the 19-kDa fragment of merozoite surface protein 1 is dependent on CD4+ Th cells. However, we found that adoptively transferred CFSE-labeled Th cells specific for an epitope on Plasmodium yoelii 19-kDa fragment of merozoite surface protein 1 (peptide (p)24), but not OVA-specific T cells, were deleted as a result of P. yoelii infection. As a result of infection, spleen cells recovered from infected p24-specific T cell-transfused mice demonstrated reduced response to specific Ag. A higher percentage of CFSE-labeled p24-specific T cells stained positive with annexin and anti-active caspase-3 in infected compared with uninfected mice, suggesting that apoptosis contributed to deletion of p24-specific T cells during infection. Apoptosis correlated with increased percentages of p24-specific T cells that stained positive for Fas from infected mice, suggesting that P. yoelii-induced apoptosis is, at least in part, mediated by Fas. However, bystander cells of other specificities also showed increased Fas expression during infection, suggesting that Fas expression alone is not sufficient for apoptosis. These data have implications for the development of immunity in the face of endemic parasite exposure.
This article has been cited by other articles:
|
|
 |
|
  J. Wipasa, H. Xu, X. Liu, C. Hirunpetcharat, A. Stowers, and M. F. Good Effect of Plasmodium yoelii Exposure on Vaccination with the 19-Kilodalton Carboxyl Terminus of Merozoite Surface Protein 1 and Vice Versa and Implications for the Application of a Human Malaria Vaccine Infect. Immun., February 1, 2009; 77(2): 817 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Freitas do Rosario, S. M. Muxel, S. M. Rodriguez-Malaga, L. R. Sardinha, C. A. Zago, S. I. Castillo-Mendez, J. M. Alvarez, and M. R. D'Imperio Lima Gradual Decline in Malaria-Specific Memory T Cell Responses Leads to Failure to Maintain Long-Term Protective Immunity to Plasmodium chabaudi AS Despite Persistence of B Cell Memory and Circulating Antibody J. Immunol., December 15, 2008; 181(12): 8344 - 8355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Elliott, T. P. Spurck, J. M. Dodin, A. G. Maier, T. S. Voss, F. Yosaatmadja, P. D. Payne, G. I. McFadden, A. F. Cowman, S. J. Rogerson, et al. Inhibition of Dendritic Cell Maturation by Malaria Is Dose Dependent and Does Not Require Plasmodium falciparum Erythrocyte Membrane Protein 1 Infect. Immun., July 1, 2007; 75(7): 3621 - 3632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. VALDERRAMA-AGUIRRE, G. QUINTERO, A. GOMEZ, A. CASTELLANOS, Y. PEREZ, F. MENDEZ, M. AREVALO-HERRERA, and S. HERRERA ANTIGENICITY, IMMUNOGENICITY, AND PROTECTIVE EFFICACY OF PLASMODIUM VIVAX MSP1 PV200L: A POTENTIAL MALARIA VACCINE SUBUNIT Am J Trop Med Hyg, November 1, 2005; 73(5_suppl): 16 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. HERRERA, A. GOMEZ, O. VERA, J. VERGARA, A. VALDERRAMA-AGUIRRE, A. MAESTRE, F. MENDEZ, R. WANG, C. E. CHITNIS, S. S. YAZDANI, et al. ANTIBODY RESPONSE TO PLASMODIUM VIVAX ANTIGENS IN FY-NEGATIVE INDIVIDUALS FROM THE COLOMBIAN PACIFIC COAST Am J Trop Med Hyg, November 1, 2005; 73(5_suppl): 44 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Stephens, F. R. Albano, S. Quin, B. J. Pascal, V. Harrison, B. Stockinger, D. Kioussis, H.-U. Weltzien, and J. Langhorne Malaria-specific transgenic CD4+ T cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearance Blood, September 1, 2005; 106(5): 1676 - 1684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. N. Wykes, Y.-H. Zhou, X. Q. Liu, and M. F. Good Plasmodium yoelii Can Ablate Vaccine-Induced Long-Term Protection in Mice J. Immunol., August 15, 2005; 175(4): 2510 - 2516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. Urban, T. T. Hien, N. P. Day, N. H. Phu, R. Roberts, E. Pongponratn, M. Jones, N. T. H. Mai, D. Bethell, G. D. H. Turner, et al. Fatal Plasmodium falciparum Malaria Causes Specific Patterns of Splenic Architectural Disorganization Infect. Immun., April 1, 2005; 73(4): 1986 - 1994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Elliott, R. D. Kuns, and M. F. Good Heterologous Immunity in the Absence of Variant-Specific Antibodies after Exposure to Subpatent Infection with Blood-Stage Malaria Infect. Immun., April 1, 2005; 73(4): 2478 - 2485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. SUPHAVILAI, S. LOOAREESUWAN, and M. F. GOOD ANALYSIS OF CIRCUMSPOROZOITE PROTEIN-SPECIFIC IMMUNE RESPONSES FOLLOWING RECENT INFECTION WITH PLASMODIUM VIVAX Am J Trop Med Hyg, July 1, 2004; 71(1): 29 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Struik, F. M. Omer, K. Artavanis-Tsakonas, and E. M. Riley Uninfected erythrocytes inhibit Plasmodium falciparum-induced cellular immune responses in whole-blood assays Blood, April 15, 2004; 103(8): 3084 - 3092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. Gavrilescu and E. Y. Denkers Apoptosis and the Balance of Homeostatic and Pathologic Responses to Protozoan Infection Infect. Immun., November 1, 2003; 71(11): 6109 - 6115. [Full Text] [PDF]
|
|
|
|
|
|
L. I. Rutitzky, G. A. Mirkin, and M. J. Stadecker Apoptosis by Neglect of CD4+ Th Cells in Granulomas: A Novel Effector Mechanism Involved in the Control of Egg-Induced Immunopathology in Murine Schistosomiasis J. Immunol., August 15, 2003; 171(4): 1859 - 1867. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wipasa, C. Hirunpetcharat, Y. Mahakunkijcharoen, H. Xu, S. Elliott, and M. F. Good Identification of T Cell Epitopes on the 33-kDa Fragment of Plasmodium yoelii Merozoite Surface Protein 1 and Their Antibody-Independent Protective Role in Immunity to Blood Stage Malaria J. Immunol., July 15, 2002; 169(2): 944 - 951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Xu, J. Wipasa, H. Yan, M. Zeng, M. O. Makobongo, F. D. Finkelman, A. Kelso, and M. F. Good The Mechanism and Significance of Deletion of Parasite-specific CD4+ T Cells in Malaria Infection J. Exp. Med., April 1, 2002; 195(7): 881 - 892. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
